Cancer News - Treatment Options

Community Hospitals Offer a Safe Surgical Option for Some Cancer Surgeries

ScienceDaily (Feb. 2, 2010) — Low-risk patients who require certain cancer surgeries can have the procedures performed with low operative mortality rates at community hospitals, according to a new study.

http://www.sciencedaily.com/releases/2010/02/100202144039.htm

Breast Cancer Survival Improves If Herceptin Is Used With Chemotherapy

ScienceDaily (Jan. 4, 2010) — Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.

http://www.sciencedaily.com/releases/2009/12/091212141414.htm

Esophageal Cancer: Minimally Invasive Treatment Found Effective

Researchers have found that early stage cancers of the esophagus can be treated as effectively by less-invasive, organ-sparing endoscopic therapy as compared to more complex surgical removal of the esophagus, according to a Mayo Clinic study published in the September 2009 issue of Gastroenterology.

http://www.medicalnewstoday.com/articles/162678.php

Grapefruit juice found to give cancer treatment a boost
Doctors say chemicals in juice prevent enzyme from breaking down certain drugs, boosting their effects

This spring, at the American Association for Cancer Research's 100th annual meeting in Denver, Cohen presented early results that showed drug levels in patients taking rapamycin once a week and drinking 8 ounces of grapefruit juice every day were similar to the levels expected from taking the drug daily without juice.

http://www.baltimoresun.com/health/chi-grapefruit-juice-05-aug05,0,28643...

Sensitizing Tumor Response To Cancer Therapy

ScienceDaily (Aug. 5, 2009) — Two forms of skin and brain cancer respond very poorly to chemotherapy and radiation: melanoma and glioblastoma multiforme brain cancer.

http://www.sciencedaily.com/releases/2009/08/090805150528.htm

Question over lymph node removal in colorectal cancer

Colorectal cancer is the third most common type of cancer and also the third leading cause of cancer death in the United States. Some patients will have localized colorectal cancers, while others will have a tumor that spreads.

http://www.healthandage.com/question-over-lymph-node-removal-in-colorect...

Seed implants suitable prostate cancer treatment for men of all ages

Men diagnosed with prostate cancer have a number of treatments to choose from, but it's a daunting task to figure out the right mix of therapies for an individual patient.

Trends among medical professionals have tipped the scales in favor of some treatments for younger men diagnosed with prostate cancer, but a new study by scientists at The Feinstein Institute for Medical Research and North Shore-LIJ Health System have found that age doesn't make a difference in the long-term therapeutic outcome.

http://www.news-medical.net/news/20090803/Seed-implants-suitable-prostat...

High-dose radiotherapy improves prostate cancer control in all patients

MedWire News: High-dose radiotherapy (HDRT) offers better protection against prostate cancer biochemical recurrence than conventional-dose radiotherapy (CDRT), regardless of risk status, conclude Brazilian scientists.

http://www.medwire-news.md/46/83748/Oncology/High-dose_radiotherapy_impr...

Endoscopic Surgery As Effective Open Surgery For Nasal Cancer

ScienceDaily (July 29, 2009) — Researchers from Boston University School of Medicine (BUSM) have shown that endoscopic surgery is a valid treatment option for treating esthesioneuroblastoma (cancer of the nasal cavity), in addition to traditional open surgery and nonsurgical treatments.
http://www.sciencedaily.com/releases/2009/07/090707131832.htm

Stanford Study Bolsters Case for Preventive Prostate Cancer Treatment

BusinessWire - For the last six years, doctors have faced a dilemma about whether to treat men at risk of prostate cancer with the drug finasteride. On one hand, the drug had been shown to prevent cancer in about one of every four patients who received it. On the other, those who did develop cancer while on the drug were 25 percent more likely to have a more aggressive form of the disease.

http://www.forbes.com/feeds/businesswire/2009/07/07/businesswire12646191...